Registered entities
ASYLIA THERAPEUTICS, INC.
Reg. No. 32073611595United States
Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 324 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Investor mix
2 investors on record; lead investors include Sporos Bioventures.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
